About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Hcsttm1.1Cln
targeted mutation 1.1, Marco Colonna
MGI:2446491
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Hcsttm1.1Cln/Hcsttm1.1Cln B6.129P2-Hcsttm1.1Cln MGI:3840592
hm2
 		Hcsttm1.1Cln/Hcsttm1.1Cln involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 MGI:3818337
hm3
 		Hcsttm1.1Cln/Hcsttm1.1Cln involves: 129P2/OlaHsd * C57BL/6 MGI:3818417
cx4
 		Hcsttm1.1Cln/Hcsttm1.1Cln
Tyrobptm1Lll/Tyrobptm1Lll 		B6.Cg-Hcsttm1.1Cln Tyrobptm1Lll MGI:3843528


Genotype
MGI:3840592
hm1
Allelic
Composition		 Hcsttm1.1Cln/Hcsttm1.1Cln
Genetic
Background		 B6.129P2-Hcsttm1.1Cln
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hcsttm1.1Cln mutation (0 available); any Hcst mutation (9 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
skeleton
abnormal osteoclast differentiation ( J:147155 )
• in vitro osteoclastogenesis from bone marrow-derived monocyte/macrophage lineage cells is impaired, especially at suboptimal concentrations of RANKL and M-CSF, compared to similarly treated wild-type cells
• however, osteoblast growth and differentiation are normal
abnormal osteoclast physiology ( J:147155 )
• at 6 months, osteoclast function is decreased compared to in wild-type mice
abnormal long bone metaphysis morphology ( J:147155 )
• at 6 months, mice exhibit a slight increase in metaphyses compared to wild-type mice
increased bone volume ( J:147155 )
• at 6 months, bone volume to tissue volume is increased compared to in wild-type mice
• however, bone volume to tissue volume is normal at 1.5 and 3 months of age
abnormal trabecular bone morphology ( J:147155 )
• at 6 months, mice exhibit a slight increase in trabecular bones compared to wild-type mice
osteopetrosis ( J:147155 )
• at 6 months, mice exhibit slight increases in metaphyses and trabecular bones compared to wild-type mice

immune system
abnormal osteoclast differentiation ( J:147155 )
• in vitro osteoclastogenesis from bone marrow-derived monocyte/macrophage lineage cells is impaired, especially at suboptimal concentrations of RANKL and M-CSF, compared to similarly treated wild-type cells
• however, osteoblast growth and differentiation are normal
abnormal osteoclast physiology ( J:147155 )
• at 6 months, osteoclast function is decreased compared to in wild-type mice

hematopoietic system
abnormal osteoclast differentiation ( J:147155 )
• in vitro osteoclastogenesis from bone marrow-derived monocyte/macrophage lineage cells is impaired, especially at suboptimal concentrations of RANKL and M-CSF, compared to similarly treated wild-type cells
• however, osteoblast growth and differentiation are normal
abnormal osteoclast physiology ( J:147155 )
• at 6 months, osteoclast function is decreased compared to in wild-type mice

cellular
abnormal osteoclast differentiation ( J:147155 )
• in vitro osteoclastogenesis from bone marrow-derived monocyte/macrophage lineage cells is impaired, especially at suboptimal concentrations of RANKL and M-CSF, compared to similarly treated wild-type cells
• however, osteoblast growth and differentiation are normal




Genotype
MGI:3818337
hm2
Allelic
Composition		 Hcsttm1.1Cln/Hcsttm1.1Cln
Genetic
Background		 involves: 129P2/OlaHsd * BALB/cJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hcsttm1.1Cln mutation (0 available); any Hcst mutation (9 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
immune system phenotype ( J:80426 )
N
• mice exhibit normal immune system development
decreased CD8-positive, alpha-beta T cell number ( J:80426 )
• following vaccination and re-challenge with RMAS.Raet1c cells, mice lack an IFN-gamma-secreting CD8+ T cell population that accumulates within tumors in similarly treated wild-type mice
impaired natural killer cell mediated cytotoxicity ( J:80426 )
• NK cell killing of RMAS.Raet1c or YAC cells is less efficient than that of wild-type mice
• NK cell surveillance exhibits reduced tumor rejection response following inoculation with RMAS tumor cells expressing Raet1c

hematopoietic system
decreased CD8-positive, alpha-beta T cell number ( J:80426 )
• following vaccination and re-challenge with RMAS.Raet1c cells, mice lack an IFN-gamma-secreting CD8+ T cell population that accumulates within tumors in similarly treated wild-type mice
impaired natural killer cell mediated cytotoxicity ( J:80426 )
• NK cell killing of RMAS.Raet1c or YAC cells is less efficient than that of wild-type mice
• NK cell surveillance exhibits reduced tumor rejection response following inoculation with RMAS tumor cells expressing Raet1c




Genotype
MGI:3818417
hm3
Allelic
Composition		 Hcsttm1.1Cln/Hcsttm1.1Cln
Genetic
Background		 involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hcsttm1.1Cln mutation (0 available); any Hcst mutation (9 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
reproductive system
abnormal maternal decidual layer morphology ( J:100668 )
• embryo implantation sites are hypocellular compared to in wild-type mice
• at E10, the mesometrial lymphoid aggregate of pregnancy is enlarged compared to in wild-type mice
• however, decidual spiral artery develops normally
abnormal decidua basalis morphology ( J:100668 )
• at E10 and E12, the deciduas basalis is larger compared to in wild-type mice
decreased uterine NK cell number ( J:100668 )
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy but not the deciduas basalis
reduced fertility ( J:100668 )
• fewer mice become pregnant following mating compared to wild-type mice
• early post-implantation (E6 and E8) and midgestational (E10) fetal losses are greater than in wild-type mice

embryo
abnormal maternal decidual layer morphology ( J:100668 )
• embryo implantation sites are hypocellular compared to in wild-type mice
• at E10, the mesometrial lymphoid aggregate of pregnancy is enlarged compared to in wild-type mice
• however, decidual spiral artery develops normally
abnormal decidua basalis morphology ( J:100668 )
• at E10 and E12, the deciduas basalis is larger compared to in wild-type mice
decreased uterine NK cell number ( J:100668 )
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy but not the deciduas basalis

immune system
decreased uterine NK cell number ( J:100668 )
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy but not the deciduas basalis
decreased interferon-gamma secretion ( J:100668 )
• at E10 in the mesometrial lymphoid aggregate of pregnancy

hematopoietic system
decreased uterine NK cell number ( J:100668 )
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy but not the deciduas basalis

endocrine/exocrine glands
decreased uterine NK cell number ( J:100668 )
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy but not the deciduas basalis




Genotype
MGI:3843528
cx4
Allelic
Composition		 Hcsttm1.1Cln/Hcsttm1.1Cln
Tyrobptm1Lll/Tyrobptm1Lll
Genetic
Background		 B6.Cg-Hcsttm1.1Cln Tyrobptm1Lll
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hcsttm1.1Cln mutation (0 available); any Hcst mutation (9 available)
Tyrobptm1Lll mutation (1 available); any Tyrobp mutation (10 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
abnormal NK T cell physiology ( J:147867 )
• NK cells fail to kill m157-expressing target cells unlike wild-type cells
abnormal response to infection ( J:147867 )
• 4 days after infection with mouse cytomegalovirus, mice exhibit higher titers than in similarly treated Tyrobptm1Lll homozygotes

hematopoietic system
abnormal NK T cell physiology ( J:147867 )
• NK cells fail to kill m157-expressing target cells unlike wild-type cells




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/23/2024
MGI 6.23 		The Jackson Laboratory